{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:54:21Z","timestamp":1791824061252,"version":"4.3.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The synthetic opioid landscape continues to change as non-fentanyl-related substances appear in forensic toxicology casework. Among the newest synthetic opioids to emerge is isotonitazene, an analogue of a benzimidazole class of analgesic compounds. Isotonitazene is an active and potent synthetic opioid, but the extent to which this compound is causing toxicity among drug users was previously unknown. This report describes the confirmation and quantitation of isotonitazene in blood, urine and vitreous fluid through standard addition, as well as in vivo metabolic profile determination in drug users. Quantitative analysis was performed using liquid chromatography tandem mass spectrometry (LC\u2013MS\/MS), and metabolite discovery was performed using liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). In total, 18 cases were confirmed positive for isotonitazene, nine of which were previously negative for any opioid. The average isotonitazene concentration in blood was 2.2\u00a0\u00b1\u00a02.1\u00a0ng\/mL (median 1.75\u00a0ng\/mL, range 0.4\u20139.5\u00a0ng\/mL), and the average isotonitazene concentration in urine was 2.4\u00a0\u00b1\u00a01.4\u00a0ng\/mL (median 2.7\u00a0ng\/mL, range 0.6\u20134.0\u00a0ng\/mL). The lowest concentration of isotonitazene in blood was 0.4\u00a0ng\/mL (two cases) with no other opioids present; findings in death investigations. Four metabolites of isotonitazene were detected in vivo. N- and O-dealkylation products were determined to be the most prominent urinary biomarkers, while 5-amino-isotonitazene was identified in most blood samples. The prevalence and popularity of isotonitazene continue to increase in the United States in early 2020. Toxicologists, medical examiners and coroners should be aware of novel opioids outside the standard scope of testing, especially in medicolegal death investigations. Forensic scientists should add isotonitazene to testing procedures, and public health officials should counsel about potent new drugs and the dangers of opioid use.<\/jats:p>","DOI":"10.1093\/jat\/bkaa016","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T07:19:23Z","timestamp":1582096763000},"page":"521-530","source":"Crossref","is-referenced-by-count":143,"title":["Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework"],"prefix":"10.1093","volume":"44","author":[{"given":"Alex J","family":"Krotulski","sequence":"first","affiliation":[{"name":"Center for Forensic Science Research and Education at the Fredric Rieders Family Foundation, 2300 Stratford Ave, Willow Grove, PA 19090, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M","family":"Papsun","sequence":"additional","affiliation":[{"name":"Toxicology Department, NMS Labs, 200 Welsh Rd, Horsham, PA 19044, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri L","family":"Kacinko","sequence":"additional","affiliation":[{"name":"Toxicology Department, NMS Labs, 200 Welsh Rd, Horsham, PA 19044, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry K","family":"Logan","sequence":"additional","affiliation":[{"name":"Center for Forensic Science Research and Education at the Fredric Rieders Family Foundation, 2300 Stratford Ave, Willow Grove, PA 19090, USA"},{"name":"Toxicology Department, NMS Labs, 200 Welsh Rd, Horsham, PA 19044, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"key":"2020073105271034100_ref1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1556-4029.2008.00669.x","article-title":"An epidemic of illicit fentanyl deaths in Cook County, Illinois: September 2005 through April 2007","volume":"53","author":"Denton","year":"2008","journal-title":"Journal of Forensic Sciences"},{"key":"2020073105271034100_ref2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: fentanyl and non-pharmaceutical fentanyls","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"2020073105271034100_ref3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"2020073105271034100_ref4","first-page":"709","article-title":"Analysis of novel synthetic opioids U-47700, U-50488 and furanyl fentanyl by LC\u2013MS\/MS in postmortem casework","volume":"40","author":"Mohr","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"2020073105271034100_ref5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/jat\/bkx068","article-title":"Observed carfentanil concentrations in 355 blood specimens from forensic investigations","volume":"41","author":"Papsun","journal-title":"Journal of Analytical Toxicology"},{"key":"2020073105271034100_ref6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.15585\/mmwr.mm6643e1","article-title":"Deaths involving fentanyl, fentanyl Analogs, and U-47700\u201410 states, July\u2013December 2016","volume":"66","author":"O\u2019Donnell","year":"2017","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"2020073105271034100_ref7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1373\/clinchem.2017.281626","article-title":"The fentanyl epidemic and evolution of fentanyl analogs in the United States and the European Union","volume":"65","author":"Jannetto","year":"2019","journal-title":"Clinical Chemistry"},{"key":"2020073105271034100_ref8","volume-title":"Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I","author":"Drug Enforcement Administration","year":"2018"},{"key":"2020073105271034100_ref9","article-title":"Drug overdose deaths in the United States, 1999\u20132016.","volume-title":"NCHS Data Brief","author":"Hedegaard","year":"2017"},{"key":"2020073105271034100_ref10","doi-asserted-by":"publisher","DOI":"10.1111\/1556-4029.14184","article-title":"Sample mining and data mining: combined real-time and retrospective approaches for the identification of emerging novel psychoactive substances","author":"Krotulski","year":"2019","journal-title":"Journal of Forensic Sciences"},{"key":"2020073105271034100_ref11","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2738","article-title":"Report on a novel emerging class of highly potent benzimidazole NPS opioids: chemical and in vitro functional characterization of isotonitazene","author":"Blanckaert","journal-title":"Drug Testing and Analysis"},{"key":"2020073105271034100_ref12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/BF02161116","article-title":"Synthese basisch substituierter, analgetisch wirksamer benzimidazol-derivate","volume":"13","author":"Hunger","year":"1957","journal-title":"Experientia"},{"key":"2020073105271034100_ref13","first-page":"935,514","article-title":"Benzimidazoles","volume":"2","author":"Hoffmann","year":"1960","journal-title":"United States Patent Office"},{"key":"2020073105271034100_ref14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00405575","article-title":"Factors regulating oral consumption of an opioid (etonitazene) by morphine-addicted rats","volume":"5","author":"Wikler","year":"1963","journal-title":"Psychopharmacologia"},{"key":"2020073105271034100_ref15","article-title":"Novel psychoactive substances (NPS) detection in Alberta casework","author":"Brooks-Lim","year":"2019"},{"key":"2020073105271034100_ref16","volume-title":"Isotonitazene","author":"Krotulski","year":"2019"},{"key":"2020073105271034100_ref17","article-title":"Potent synthetic opioid\u2014Isotonitazene\u2014Recently identified in the Midwestern United States","author":"Krotulski","year":"2019","journal-title":"NPS Discovery"},{"key":"2020073105271034100_ref18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1021\/ed057p703","article-title":"A systematic approach to standard addition methods in instrumental analysis","volume":"57","author":"Bader","year":"1980","journal-title":"Journal of Chemical Education"},{"key":"2020073105271034100_ref19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/jat\/bkv078","article-title":"Quantification of drugs in brain samples","volume":"39","author":"Reiter","year":"2015","journal-title":"Journal of Analytical Toxicology"},{"key":"2020073105271034100_ref20","article-title":"Standard for mass spectral data acceptance in forensic toxicology","author":"Organization of Scientific Area Committees for Forensic Science.","year":"2019"},{"key":"2020073105271034100_ref21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/bkt054","article-title":"Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology","volume":"37","author":"Scientific Working Group for Forensic Toxicology","year":"2013","journal-title":"Journal of Analytical Toxicology"},{"key":"2020073105271034100_ref22","article-title":"Metabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug users","author":"Krotulski","year":"2017","journal-title":"Drug Testing and Analysis"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkaa016\/33159139\/bkaa016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/44\/6\/521\/33552679\/bkaa016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/44\/6\/521\/33552679\/bkaa016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T05:30:15Z","timestamp":1596173415000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/44\/6\/521\/5753838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,2,24]]},"published-print":{"date-parts":[[2020,7,31]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkaa016","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,2,24]]}}}